Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

173 results about "Titin Antibody" patented technology

The antibody localizes titin (connectin) in skeletal and heart muscle of a wide variety of species from cold-blooded vertebrates to human. The antibody does not cross-react with nebulin.

ELISA kit of IBDV antibodies, test method and effective antibody titer determination method

The invention discloses an ELISA kit of IBDV antibodies, a test method and an effective antibody titer determination method. The ELISA kit comprises (1) an enzyme-labeled board coated with IBDV antigens and (2) goat anti-chicken Ig Y diluted according to the ratio of 1:3,000 and marked with HRP, wherein the enzyme-labeled board coated with the IBDV antigens is made by diluting the concentration ofthe IBDV antigens to 10ng / pore and then coating corresponding pores in a reaction board with diluent, the IBDV antigens are rVP2 proteins prepared through a baculovirus expression system, and a detection result is judged according to an S / P value obtained through an ELISA detection method. When the detection result is positive according to the S / P value obtained through the ELISA detection method, it is indicated that effective antibodies are in a high level and can neutralize IBDVs, and therefore it is needless to perform vaccine immunization again; and when the detection result is negativeaccording to the S / P value, it is indicated that the antibodies are in a low level without protective force and are prone to being infected by viruses, and therefore it is needed to perform vaccine immunization again. As a result, the established ELISA kit has a high antibody positivity detection rate and can guide vaccine immunization on production to reduce economic losses.
Owner:XINXIANG UNIV

Application of Shuanghuanglian oral liquor in preparation of medicine for treating and preventing poultry virosis

The invention belongs to the technical field of veterinary medicines, particularly relates to an application of Shuanghuanglian oral liquor in preparation of a medicine for treating and preventing poultry virosis, and in particular relates to an application of Shuanghuanglian oral liquor in preparation of a medicine for treating and preventing newcastle disease or infectious bronchitis. As the experiments show, the Shuanghuanglian oral liquor has an excellent effect on immunological enhancement respect to newcastle disease and infectious bronchitis bivalent inactivated vaccines (LaSota-M41 strains), can be used for obviously improving the antibody level as well as the immune protective effects of the newcastle disease and infectious bronchitis bivalent inactivated vaccines (LaSota-M41 strains), and also can be used for improving the infectious bronchitis virus serum antibody titer, and as a result, the anti-excitability ability of the poultry organisms is improved.
Owner:HENAN XINZHENGHAO BIO ENG

Competitive enzyme-linked immunosorbent assay method of EV71 neutralizing antibody, kit or reagent and prepration method thereof

ActiveCN101609097AGuaranteed specificityOvercome the inability to carry out the shortcomingsFermentationMaterial analysisAntigenSerum reaction
The invention discloses a competitive enzyme-linked immunosorbent assay method of an EV71 neutralizing antibody, a kit or a reagent and a preparation method thereof. The kit utilizes the labeled monoclonal antibody which has higher neutralizing potency on three genes of A, B and C of EV71 virus, a reference material of the EV71 neutralizing antibody and a coated plate and can simply, rapidly and accurately carry out qualitative and quantitative assay on the content of the EV71 neutralizing antibody in a human sample or an animal sample. EV71 virus particles are coated on the ELISA plate, the enzyme-labeled EV71 neutralizing antibody is diluted according to a certain proportion, then respectively mixed with the sample to be assayed and the reference material of the EV71 neutralizing antibody and reacted with an EV71 antigen coated on the ELISA plate, a semi-logarithmic standard curve is drawn according to the absorptance percentage of OD value of the reference serum reaction and the logarithm of the potency of the reference material of the EV71 neutralizing antibody after color development, and the absorptance percentage of the OD value of the sample to be assayed is substituted ina standard curve equation to calculate the corresponding neutralizing potency.
Owner:SINOVAC BIOTECH

ETEC (enterotoxigenic escherichla coli) yolk antibody powder and preparation method thereof

The invention discloses ETEC (enterotoxigenic escherichla coli) yolk antibody powder and a preparation method thereof. The method comprises following steps: escherichia coli strains are cultured in a solid culture medium at 35-40 DEG C for 18-24 h; after culture, pilin is extracted coarsely from the solid culture medium and is purified; the purified pilin and equal volume of a freund's adjuvant are mixed, an oil-emulsion vaccine is formed and used for immunizing a primiparous hen, and serum and a yolk antibody are collected after immunization; the yolk antibody is subjected to spray drying through a powder sprayer, and the yolk antibody powder is prepared. Analysis of the titer of the immunized yolk antibody with ELISA (enzyme-linked immunosorbent assay) discovers that higher-titer yolk antibody can be obtained by using purified pilin as an antigen for immunization. After the yolk antibody powder is prepared from the yolk antibody through spray drying by the powder sprayer, the antibody titer is only reduced by one degree of multiple proportions, the yolk antibody has very good high-temperature stability, and a power preparation process adopting a spray drying method is applicable to production of the yolk antibody powder.
Owner:FOSHAN UNIVERSITY

Intravenously injected cytomegalovirus human immune globulin and preparation method thereof

The invention relates to intravenously injected cytomegalovirus human immune globulin and a preparation method thereof, and the titer of a cytomegalovirus neutralizing antibody of the human immune globulin is larger than or equal to 1:500. The preparation method comprises the steps that 1, positive plasma with the titer of the cytomegalovirus neutralizing antibody larger than or equal to 1:20 is screened out; 2, the screened-out efficient positive plasma is mixed; 3, the mixed plasma is separated through a low-temperature ethanol filter-pressing method, an immune globulin component II is separated and purified by combining an ion-exchange column chromatography method, viruses are removed through filtration, chromatography, ultrafiltration, preparation, low-pH incubation virus inactivation and nanofilm filtration, the immune globulin with the purity of 98.5%-100% is obtained through subpackaging, and the antibody titer is not lower than 1:500. The cytomegalovirus human immune globulin prepared through the preparation and production method is high in antibody titer, purity and recovery rate and capable of conducting targeted treatment on cytomegalovirus, is an effectively drug for treating recessive and dominant infection caused by the cytomegalovirus in people, is safe and reliable and has larger social benefits and economic benefits.
Owner:哈尔滨派斯菲科生物制药有限公司

Hydrophobia, tetanus double-titer human immunoglobulin and preparation method thereof

The invention relates to a rabies and tetanus double valence human normal immunoglobulin, the rabies valence of antibody is not less than 100IU / mL, the tetanus valence of antibody is not less than 60IU / mL, the content of protein is not more than 175g / L, the immunoglobulin purity is not lower than 92% of the total protein content. The preparation method of source plasma of the protein is to select plasma supplier to be inoculated with rabies vaccine and then with adsorbed tetanus vaccine at least 1-5 days later to obtain the source plasma with rabies valence of antibody being not less than 6IU / mL and the tetanus valence of antibody being not less than 5IU / mL and ensure that the rabies valence of antibody of the source plasma is not less than 10IU / m and the tetanus valence of antibody is not less than 8IU / mL after mixture. The immunoglobulin of the invention can be used to immunize patients suffering exposed wounds caused by biting and scratching of a mad dog or other mad animals.
Owner:SHANXI KANGBAO BIOLOGICAL PROD

Synthesis method and application of coumafuryl hapten

The invention provides a synthesis method and an application of a coumafuryl hapten. The structural formula of the coumafuryl hapten is shown in the description. The coumafuryl hapten is prepared by acondensation reaction of coumafuryl and carboxymethyl hydroxylamine semi-hydrochloride. The invention also provides a coumafuryl artificial antigen. The coumafuryl artificial antigen is prepared by coupling the coumafuryl hapten with a carrier protein. The complete antigen of the coumafuryl hapten prepared by the synthesis method of the coumafuryl hapten can expose the chemical structure of the coumafuryl as an antigen determinant, so a foundation is laid for the preparation of a high-sensitivity anti-coumafuryl antibody. Finally, an antibody CF-CMO-BSA-3 # with optimal properties is obtainedthrough screening, the highest titer can reach 3.2 * 10<4>, and the sensitivity is 0.32 ng / mL. A coumafuryl polyclonal antibody prepared from the coumafuryl hapten has the unique advantages of high sensitivity, high practical value and the like, and has a good application prospect in public health safety detection.
Owner:CHINA AGRI UNIV

Specific egg-yolk antibody for preventing and treating feline distemper and preparation method of specific egg-yolk antibody

The invention discloses a specific egg-yolk antibody for preventing and treating feline distemper. The specific egg-yolk antibody is prepared by taking FPV inactivated vaccine and FPV subunit vaccineas immunogens and using immune laying hens. Accordingly, a corresponding preparation method is established and comprises the following steps: creatively inoculating laying hens with two different FPVimmunogens, taking the FPV inactivated vaccine as a basic immunogen and the FPV subunit vaccine as a strengthened immunogen; optimizing an immunization method and inoculation dose to produce high antibody titer; immunizing the laying hens, then harvesting eggs from hype-immunized chickens, separating egg yolk, and extracting and purifying a coarse product of the yolk antibody, thus obtaining the specific egg-yolk antibody for preventing and treating the feline distemper. The test shows that the yolk antibody disclosed by the invention has the advantages of good safety, high specificity, high antibody titer, low cost and high yield; the specific egg-yolk antibody can be used for treatment and emergency prevention of the feline distemper and enhancing the resistance of sick cats and has a good popularization and application prospect.
Owner:GUANGXI VETERINARY RES INST

Preparation method of piperacillin monoclonal antibody and application

The invention relates to a preparation method of a piperacillin monoclonal antibody and application. A hybridoma cell strain is utilized for preparation. The preparation method comprises the followingsteps: preparing a piperacillin monoclonal antibody, performing antibody purification, performing antibody purity identification and performing antibody titer identification. The prepared piperacillin monoclonal antibody is used for detecting piperacillin drug antibodies. Blood of a detected object serves as a detection sample, if the piperacillin antibody exists in plasma, the antibody is boundto a piperacillin drug antigen on piperacillin treated cells by virtue of anti-IgG+G3d bridging so as to produce agglutination, the antibody cannot pass through a gel space and remains on the upper layer of the gel or is dispersed into the gel under the effect of centrifugal force, and presents a positive reaction; and if any antibody does not exist in the plasma or the cell surface does not contain any drug antigen, agglutination is not produced, and the antibody can pass through the gel space to deposit at the bottom of a micro-column gel hole under the effect of the centrifugal force and presents a negative reaction.
Owner:江苏中济万泰生物医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products